Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$47.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 3 |
Phillips 66
PSX
|
+$34.7M |
| 4 |
Chevron
CVX
|
+$31.9M |
| 5 |
Johnson Controls International
JCI
|
+$31.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$51.8M |
| 2 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$49.5M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$48.2M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$37.7M |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.69% |
| 2 | Industrials | 11.81% |
| 3 | Healthcare | 11.19% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
HDFC Bank
HDB
$121B
| $10.9M | 0.17% |
326,814
+271,080
| +486% | +$9.06M |
|
127
Universal Health Services
UHS
$10.4B
| $10.9M | 0.17% |
+85,488
| New | +$11.8M |
|
128
Zoom
ZM
$31.5B
| $10.8M | 0.17% |
146,671
+56,338
| +62% | +$4.06M |
|
129
Rexford Industrial Realty
REXR
$8.3B
| $10.8M | 0.17% |
+181,345
| New | +$10.9M |
|
130
Extra Space Storage
EXR
$31B
| $10.8M | 0.17% |
66,074
+23,079
| +54% | +$3.63M |
|
131
Otis Worldwide
OTIS
$27.2B
| $10.8M | 0.17% |
127,499
| – | – |
|
132
JD.com
JD
$39.7B
| $10.6M | 0.16% |
242,129
+187,725
| +345% | +$9.7M |
|
133
Williams Companies
WMB
$86.2B
| $10.6M | 0.16% |
355,716
+289,185
| +435% | +$8.93M |
|
134
HEICO Corp
HEI
$49.6B
| $10.6M | 0.16% |
61,937
+44,138
| +248% | +$7.43M |
|
|
HCP
135
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $10.4M | 0.16% |
356,397
+149,534
| +72% | +$4.46M |
|
136
Oshkosh
OSK
$9.7B
| $10.3M | 0.16% |
123,718
+71,078
| +135% | +$6.45M |
|
137
Atkore
ATKR
$3.16B
| $10.3M | 0.16% |
73,109
+11,320
| +18% | +$1.53M |
|
138
Teva Pharmaceuticals
TEVA
$43.5B
| $10.2M | 0.16% |
1,157,978
+11,859
| +1% | +$117K |
|
139
WIX.com
WIX
$3.43B
| $10.2M | 0.16% |
102,690
-4,439
| -4% | -$390K |
|
|
CFLT
140
DELISTED
Confluent
CFLT
| $10.2M | 0.16% |
424,536
-3,442
| -0.8% | -$79.8K |
|
141
PUT
T-Mobile US
TMUS
$196B
| $10.1M | 0.16% |
+70,000
| New | +$10.1M |
|
142
Agree Realty
ADC
$9.19B
| $10M | 0.15% |
145,913
+57,111
| +64% | +$4.08M |
|
|
SPLK
143
DELISTED
Splunk Inc
SPLK
| $10M | 0.15% |
+104,412
| New | +$10M |
|
144
British American Tobacco
BTI
$121B
| $9.97M | 0.15% |
283,758
+202,360
| +249% | +$7.63M |
|
145
PUT
Texas Instruments
TXN
$241B
| $9.88M | 0.15% |
53,100
+37,000
| +230% | +$6.51M |
|
146
HCA Healthcare
HCA
$92.9B
| $9.84M | 0.15% |
37,308
+1,148
| +3% | +$292K |
|
|
USX
147
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $9.8M | 0.15% |
+1,650,000
| New | +$3.86M |
|
148
Lam Research
LRCX
$393B
| $9.8M | 0.15% |
184,840
+156,540
| +553% | +$7.68M |
|
149
Steel Dynamics
STLD
$32.8B
| $9.78M | 0.15% |
86,462
+55,788
| +182% | +$6.49M |
|
150
Progressive
PGR
$127B
| $9.77M | 0.15% |
68,266
+2,873
| +4% | +$396K |
|
Similar funds
Paul Tudor Jones's Q1 2023 Portfolio in Review
As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.
- Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
- Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
- Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
- Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
- Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
- Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
- Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.
Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.